Working Group 4 meeting. EU-COST Action CM1105 - Overcoming cisplatin and oxaliplatin resistance in vitro using small-molecule osmium antineoplastics
- Romero Canelon, I. (Chair)
Activity: Academic and Industrial events › Guest lecture or Invited talk